New generation of breast cancer clinical trials implementing molecular profiling

by Dimitrios Zardavas, Martine Piccart-Gebhart
Published 2016-06-01

Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: no longer an ‘option’ but an ethical obligation

by Mariana Brandão, Fabien Reyal, Anne-Sophie Hamy, Martine Piccart-Gebhart
Published 2019-06-01

Late effects of adjuvant chemotherapy adumbrate dormancy complexity in breast cancer

by Romano Demicheli, Christine Desmedt, Mike Retsky, Christos Sotiriou, Martine Piccart, Elia Biganzoli
Published 2020-08-01

Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives

by Rafael Caparica, Matteo Lambertini, Noam Pondé, Debora Fumagalli, Evandro de Azambuja, Martine Piccart
Published 2019-02-01

Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA.

by Felipe Ades, Christelle Senterre, Dimitrios Zardavas, Evandro de Azambuja, Razvan Popescu, Martine Piccart
Published 2017-01-01

Adenoid cystic carcinoma of the breast – an aggressive presentation with pulmonary, kidney, and brain metastases: a case report

by Hasnae Alaoui Mhamdi, Hampig Raphael Kourie, Christiane Jungels, Philippe Aftimos, Rhizlane Belbaraka, Martine Piccart-Gebhart
Published 2017-10-01

HER2-Low Breast Cancer: Molecular Characteristics and Prognosis

by Elisa Agostinetto, Mattia Rediti, Danai Fimereli, Véronique Debien, Martine Piccart, Philippe Aftimos, Christos Sotiriou, Evandro de Azambuja
Published 2021-06-01

Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence

by José R. Rossari, Otto Metzger-Filho, Marianne Paesmans, Kamal S. Saini, Alessandra Gennari, Evandro de Azambuja, Martine Piccart-Gebhart
Published 2012-01-01

Correction: Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled in-silico Analysis

by Hatem A. Azim, Sandeep Singhal, Michail Ignatiadis, Christine Desmedt, Debora Fumagalli, Isabelle Veys, Denis Larsimont, Martine Piccart, Stefan Michiels, Christos Sotiriou
Published 2013-01-01

Correction: Association between SPARC mRNA Expression, Prognosis and Response to Neoadjuvant Chemotherapy in Early Breast Cancer: A Pooled Analysis.

by Hatem A. Azim, Sandeep Singhal, Michail Ignatiadis, Christine Desmedt, Debora Fumagalli, Isabelle Veys, Denis Larsimont, Martine Piccart, Stefan Michiels, Christos Sotiriou
Published 2013-01-01

Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysis.

by Hatem A Azim, Sandeep Singhal, Michail Ignatiadis, Christine Desmedt, Debora Fumagalli, Isabelle Veys, Denis Larsimont, Martine Piccart, Stefan Michiels, Christos Sotiriou
Published 2013-01-01

Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis

by Matteo Lambertini, Mariana Brandão, Evandro de Azambuja, Christian Maurer, Patricia Klarmann Ziegelmann, Noam F Pondé, Arlindo Ferreira, Samuel Martel, Martine Piccart, Márcio Debiasi
Published 2020-10-01

Low CD10 mRNA expression identifies high-risk ductal carcinoma in situ (DCIS).

by Jérôme Toussaint, Virginie Durbecq, Sevilay Altintas, Valérie Doriath, Ghizlane Rouas, Marianne Paesmans, Philippe Bedard, Benjamin Haibe-Kains, Wiebren A Tjalma, Denis Larsimont, Martine Piccart, Christos Sotiriou
Published 2010-01-01

Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer.

by Françoise Rothé, Michail Ignatiadis, Carole Chaboteaux, Benjamin Haibe-Kains, Naïma Kheddoumi, Samira Majjaj, Bassam Badran, Hussein Fayyad-Kazan, Christine Desmedt, Adrian L Harris, Martine Piccart, Christos Sotiriou
Published 2011-01-01

Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial

by Serena Di Cosimo, Luca Porcu, Dominique Agbor-tarh, Saverio Cinieri, Maria Alice Franzoi, Maria Carmen De Santis, Cristina Saura, Jens Huober, Debora Fumagalli, Miguel Izquierdo, Martine Piccart, Maria Grazia Daidone, Evandro de Azambuja
Published 2020-10-01

Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome

by David Venet, Danai Fimereli, Françoise Rothé, Bram Boeckx, Marion Maetens, Samira Majjaj, Ghizlane Rouas, Maria Capra, Giuseppina Bonizzi, Federica Contaldo, Christine Galant, Martine Piccart, Giancarlo Pruneri, Denis Larsimont, Diether Lambrechts, Christine Desmedt, Christos Sotiriou
Published 2020-06-01

Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial

by Alex De Caluwé, Laurence Buisseret, Philip Poortmans, Dirk Van Gestel, Roberto Salgado, Christos Sotiriou, Denis Larsimont, Marianne Paesmans, Ligia Craciun, Drisis Stylianos, Christophe Vandekerckhove, Fabien Reyal, Veys Isabelle, Daniel Eiger, Martine Piccart, Emanuela Romano, Michail Ignatiadis
Published 2021-08-01

FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancerResearch in context

by Pushpamali De Silva, Soizic Garaud, Cinzia Solinas, Alexandre de Wind, Gert Van den Eyden, Vinu Jose, Chunyan Gu-Trantien, Edoardo Migliori, Anaïs Boisson, Céline Naveaux, Hugues Duvillier, Ligia Craciun, Denis Larsimont, Martine Piccart-Gebhart, Karen Willard-Gallo
Published 2019-01-01

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer

by Andrea Gombos, David Venet, Lieveke Ameye, Peter Vuylsteke, Patrick Neven, Vincent Richard, Francois P. Duhoux, Jean-Francois Laes, Françoise Rothe, Christos Sotiriou, Marianne Paesmans, Ahmad Awada, Thomas Guiot, Patrick Flamen, Martine Piccart-Gebhart, Michail Ignatiadis, Géraldine Gebhart
Published 2021-09-01

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome

by Debora Fumagalli, David Gacquer, Françoise Rothé, Anne Lefort, Frederick Libert, David Brown, Naima Kheddoumi, Adam Shlien, Tomasz Konopka, Roberto Salgado, Denis Larsimont, Kornelia Polyak, Karen Willard-Gallo, Christine Desmedt, Martine Piccart, Marc Abramowicz, Peter J. Campbell, Christos Sotiriou, Vincent Detours
Published 2015-10-01